Literature DB >> 718677

A simple procedure for the determination of hydroxyproline in urine and bone.

J O Gordeladze, J Halse, O Djøoseland, H N Haugen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718677     DOI: 10.1016/0006-2944(78)90046-7

Source DB:  PubMed          Journal:  Biochem Med        ISSN: 0006-2944


× No keyword cloud information.
  7 in total

1.  Activation of human neutrophil gelatinase by endogenous serine proteinases.

Authors:  M C Vissers; C C Winterbourn
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

2.  Benefits of short-term muscular training in reducing the effects of muscular over-exertion.

Authors:  R Seaman; C D Ianuzzo
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

3.  Developmental changes in the activities of prolinase and prolidase in rat salivary glands, and the effect of thyroxine administration.

Authors:  K Imai; T Nagatsu; T Yajima; N Maeda; M Kumegawa; T Kato
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

4.  Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.

Authors:  B Mortensen; J O Gordeladze; L Aksnes; K M Gautvik
Journal:  Calcif Tissue Int       Date:  1990-05       Impact factor: 4.333

5.  Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.

Authors:  G Jablonski; B M Mortensen; K H Klem; L Mosekilde; C C Danielsen; J O Gordeladze
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

6.  Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption.

Authors:  G Jablonski; C C Danielsen; L Mosekilde; J O Gordeladze
Journal:  Calcif Tissue Int       Date:  1994-10       Impact factor: 4.333

7.  A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.

Authors:  T Gulliford; J English; K W Colston; P Menday; S Moller; R C Coombes
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.